Cargando…
What’s in an intron? CCN1 mRNA splicing in cancer
The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested....
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721082/ https://www.ncbi.nlm.nih.gov/pubmed/19381874 http://dx.doi.org/10.1007/s12079-009-0050-x |
_version_ | 1782170168571461632 |
---|---|
author | Leask, Andrew |
author_facet | Leask, Andrew |
author_sort | Leask, Andrew |
collection | PubMed |
description | The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested. In a recent report, Hirschfeld and colleagues (Cancer Res 69:2082-90, 2009), show that CCN1 (cyr61) mRNA is normally present in a form in which intron 3 is retained. In cancers, or upon hypoxia, intron 3 is removed resulting in the appearance of CCN1 protein. The significance of this paper is discussed. |
format | Text |
id | pubmed-2721082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-27210822009-08-06 What’s in an intron? CCN1 mRNA splicing in cancer Leask, Andrew J Cell Commun Signal Bits and Bytes The CCN family of matricellular signaling regulators shares a common domain structure. Variants of individual CCN proteins exist, which contain different combinations of these domains. Although mRNA splicing is likely to play a key role on CCN biology, this hypothesis has not been thoroughly tested. In a recent report, Hirschfeld and colleagues (Cancer Res 69:2082-90, 2009), show that CCN1 (cyr61) mRNA is normally present in a form in which intron 3 is retained. In cancers, or upon hypoxia, intron 3 is removed resulting in the appearance of CCN1 protein. The significance of this paper is discussed. Springer Netherlands 2009-04-21 2009-06 /pmc/articles/PMC2721082/ /pubmed/19381874 http://dx.doi.org/10.1007/s12079-009-0050-x Text en © The Author(s) 2009 |
spellingShingle | Bits and Bytes Leask, Andrew What’s in an intron? CCN1 mRNA splicing in cancer |
title | What’s in an intron? CCN1 mRNA splicing in cancer |
title_full | What’s in an intron? CCN1 mRNA splicing in cancer |
title_fullStr | What’s in an intron? CCN1 mRNA splicing in cancer |
title_full_unstemmed | What’s in an intron? CCN1 mRNA splicing in cancer |
title_short | What’s in an intron? CCN1 mRNA splicing in cancer |
title_sort | what’s in an intron? ccn1 mrna splicing in cancer |
topic | Bits and Bytes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721082/ https://www.ncbi.nlm.nih.gov/pubmed/19381874 http://dx.doi.org/10.1007/s12079-009-0050-x |
work_keys_str_mv | AT leaskandrew whatsinanintronccn1mrnasplicingincancer |